Menu
GeneBe

SETDB1

SET domain bifurcated histone lysine methyltransferase 1, the group of Lysine methyltransferases|Tudor domain containing|Methyl-CpG binding domain containing|SET domain containing

Basic information

Region (hg38): 1:150926262-150964744

Links

ENSG00000143379NCBI:9869OMIM:604396HGNC:10761Uniprot:Q15047AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the SETDB1 gene.

  • not provided (23 variants)
  • Inborn genetic diseases (8 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the SETDB1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
9
clinvar
2
clinvar
11
missense
9
clinvar
2
clinvar
3
clinvar
14
nonsense
0
start loss
0
frameshift
1
clinvar
1
clinvar
2
inframe indel
0
splice donor/acceptor (+/-2bp)
1
clinvar
1
splice region
2
2
non coding
1
clinvar
1
Total 0 0 11 12 6

Variants in SETDB1

This is a list of pathogenic ClinVar variants found in the SETDB1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
1-150929964-T-C Likely benign (Feb 01, 2023)779065
1-150930021-A-G Likely benign (Jul 02, 2018)746399
1-150939931-C-T Likely benign (Dec 31, 2019)723281
1-150939954-A-C Likely benign (Mar 01, 2024)3067530
1-150939977-A-G Likely benign (Mar 01, 2024)3067292
1-150941367-A-C not specified Uncertain significance (Jan 04, 2022)2269939
1-150942567-C-T Likely benign (Apr 25, 2018)741008
1-150942666-C-G Likely benign (Apr 16, 2018)740663
1-150942850-A-G Uncertain significance (Aug 01, 2018)623703
1-150942901-A-G Likely benign (Jan 19, 2018)724032
1-150942957-T-C not specified Uncertain significance (Jun 29, 2022)2298861
1-150943990-C-G not specified Uncertain significance (Jul 26, 2021)2403884
1-150944928-T-C Likely benign (Apr 25, 2018)741352
1-150945146-G-GT Benign (Mar 03, 2015)1292241
1-150946983-A-G not specified Uncertain significance (Apr 13, 2022)2284237
1-150947007-A-G not specified Uncertain significance (Apr 08, 2022)2282785
1-150949193-C-T Likely benign (Jan 31, 2018)725264
1-150949261-C-G Benign (Jan 30, 2018)722333
1-150950463-C-T Benign (Dec 31, 2019)773152
1-150950706-G-A Uncertain significance (Mar 31, 2022)2428532
1-150951098-G-C Likely benign (Jul 27, 2018)753682
1-150951416-A-G Likely benign (Aug 20, 2018)737622
1-150951422-C-G Likely benign (Mar 30, 2018)738300
1-150960754-C-G not specified Uncertain significance (Jan 09, 2024)3160699
1-150960883-G-C not specified Uncertain significance (Dec 22, 2023)3160700

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
SETDB1protein_codingprotein_codingENST00000271640 2138475
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.000.000004461257360121257480.0000477
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense4.014347410.5860.00004248483
Missense in Polyphen120350.290.342574030
Synonymous-0.3782752671.030.00001412536
Loss of Function6.69765.40.1070.00000402707

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00002910.0000291
Ashkenazi Jewish0.000.00
East Asian0.00005440.0000544
Finnish0.00004620.0000462
European (Non-Finnish)0.00007040.0000703
Middle Eastern0.00005440.0000544
South Asian0.00003270.0000327
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Histone methyltransferase that specifically trimethylates 'Lys-9' of histone H3. H3 'Lys-9' trimethylation represents a specific tag for epigenetic transcriptional repression by recruiting HP1 (CBX1, CBX3 and/or CBX5) proteins to methylated histones. Mainly functions in euchromatin regions, thereby playing a central role in the silencing of euchromatic genes. H3 'Lys-9' trimethylation is coordinated with DNA methylation. Probably forms a complex with MBD1 and ATF7IP that represses transcription and couples DNA methylation and histone 'Lys-9' trimethylation. Its activity is dependent on MBD1 and is heritably maintained through DNA replication by being recruited by CAF-1. SETDB1 is targeted to histone H3 by TRIM28/TIF1B, a factor recruited by KRAB zinc-finger proteins. Probably forms a corepressor complex required for activated KRAS-mediated promoter hypermethylation and transcriptional silencing of tumor suppressor genes (TSGs) or other tumor-related genes in colorectal cancer (CRC) cells (PubMed:24623306). Also required to maintain a transcriptionally repressive state of genes in undifferentiated embryonic stem cells (ESCs) (PubMed:24623306). Associates at promoter regions of tumor suppressor genes (TSGs) leading to their gene silencing (PubMed:24623306). The SETDB1-TRIM28-ZNF274 complex may play a role in recruiting ATRX to the 3'-exons of zinc-finger coding genes with atypical chromatin signatures to establish or maintain/protect H3K9me3 at these transcriptionally active regions (PubMed:27029610). {ECO:0000269|PubMed:12869583, ECO:0000269|PubMed:14536086, ECO:0000269|PubMed:15327775, ECO:0000269|PubMed:17952062, ECO:0000269|PubMed:24623306, ECO:0000269|PubMed:27029610}.;
Pathway
Lysine degradation - Homo sapiens (human);Signaling pathways regulating pluripotency of stem cells - Homo sapiens (human);Histone Modifications;PKMTs methylate histone lysines;Chromatin modifying enzymes;Lysine metabolism;Noncanonical Wnt signaling pathway;Chromatin organization (Consensus)

Intolerance Scores

loftool
0.0153
rvis_EVS
-1.46
rvis_percentile_EVS
3.81

Haploinsufficiency Scores

pHI
0.134
hipred
Y
hipred_score
0.833
ghis
0.615

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
S
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
1.00

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Setdb1
Phenotype
cellular phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); embryo phenotype;

Gene ontology

Biological process
Ras protein signal transduction;response to vitamin;histone lysine methylation;response to ethanol;positive regulation of methylation-dependent chromatin silencing
Cellular component
nucleus;nucleoplasm;chromosome;cytosol;plasma membrane;intracellular membrane-bounded organelle
Molecular function
DNA binding;chromatin binding;protein binding;zinc ion binding;histone-lysine N-methyltransferase activity;promoter-specific chromatin binding